Novavax Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | Outperform |
9
|
$153.50 | Buy/Sell | $174.55 | 10.75% | 3 | $363.99B |
| MRK | Merck | Outperform |
2
|
$131.10 | Buy/Sell | $130.51 | 9.08% | 11 | $331.19B |
| AZN | AstraZeneca PLC | Outperform |
17
|
£123.60 | Buy/Sell | £165.99 | 33.74% | 16 | £191.67B |
| PFE | Pfizer | Outperform |
2
|
$29.60 | Buy/Sell | $32.87 | 3.04% | 6 | $161.84B |
| GSK | GSK | Outperform |
12
|
£17.89 | Buy/Sell | £17.30 | 11.51% | 12 | £71.61B |
| MRNA | Moderna | Outperform |
16
|
$163.33 | Buy/Sell | $135.42 | -22.86% | 1 | $55.07B |
| 4502 | Takeda Pharmaceutical Company | Outperform |
5
|
¥4.10k | Buy/Sell | ¥4.74k | 9.70% | 0 | ¥6.48T |
| BNTX | BioNTech | Outperform |
12
|
$102.30 | Buy/Sell | $123.75 | -8.55% | 3 | $22.22B |
| DVAX | Dynavax Technologies | Outperform |
11
|
$11.46 | Buy/Sell | $25.00 | 118.15% | 1 | $1.52B |
| VBIV | VBI Vaccines | Outperform |
10
|
$0.65 | Buy/Sell | $6.00 | 669.23% | 0 | $18.63M |